Found: 165
Select item for more details and to access through your institution.
Northwestern University resource and education development initiatives to advance collaborative artificial intelligence across the learning health system.
- Published in:
- Learning Health Systems, 2024, v. 8, n. 3, p. 1, doi. 10.1002/lrh2.10417
- By:
- Publication type:
- Article
Circulating Growth Differentiation Factors 11 and 8, Their Antagonists Follistatin and Follistatin-Like-3, and Risk of Heart Failure in Elders.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2024, v. 79, n. 1, p. 1, doi. 10.1093/gerona/glad206
- By:
- Publication type:
- Article
Heart failure associations with cerebral structure: combined analysis from the Multi‐Ethnic Study of Atherosclerosis (MESA) and the SECRET‐II trial of heart failure with preserved ejection fraction.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.067174
- By:
- Publication type:
- Article
Insulin Resistance Is Associated with Right Ventricular Dysfunction.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Secretory leukocyte protease inhibitor and risk of heart failure in the Multi-Ethnic Study of Atherosclerosis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-27679-0
- By:
- Publication type:
- Article
Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22877-8
- By:
- Publication type:
- Article
A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22876-9
- By:
- Publication type:
- Article
Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPD.
- Published in:
- International Journal of COPD, 2017, v. 12, p. 1439, doi. 10.2147/COPD.S131413
- By:
- Publication type:
- Article
Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women's study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Four-dimensional flow assessment of pulmonary artery flow and wall shear stress in adult pulmonary arterial hypertension: Results from two institutions.
- Published in:
- Magnetic Resonance in Medicine, 2015, v. 73, n. 5, p. 1904, doi. 10.1002/mrm.25326
- By:
- Publication type:
- Article
Eicosanoid and eicosanoid-related inflammatory mediators and exercise intolerance in heart failure with preserved ejection fraction.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43363-3
- By:
- Publication type:
- Article
Right Heart Structural Changes Are Independently Associated with Exercise Capacity in Non-Severe COPD.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0029069
- By:
- Publication type:
- Article
Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.
- Published in:
- European Heart Journal, 2024, v. 45, n. 35, p. 3254, doi. 10.1093/eurheartj/ehae322
- By:
- Publication type:
- Article
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2930, doi. 10.1093/eurheartj/ehad283
- By:
- Publication type:
- Article
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2170, doi. 10.1093/eurheartj/ehad276
- By:
- Publication type:
- Article
Dapagliflozin for heart failure according to body mass index: the DELIVER trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4406, doi. 10.1093/eurheartj/ehac481
- By:
- Publication type:
- Article
BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction.
- Published in:
- European Heart Journal, 2022, v. 43, n. 20, p. 1952, doi. 10.1093/eurheartj/ehac121
- By:
- Publication type:
- Article
Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.
- Published in:
- European Heart Journal, 2018, v. 39, n. 37, p. 3439, doi. 10.1093/eurheartj/ehy531
- By:
- Publication type:
- Article
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Loss of Lung Health from Young Adulthood and Cardiac Phenotypes in Middle Age.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 192, n. 1, p. 76, doi. 10.1164/rccm.201501-0116OC
- By:
- Publication type:
- Article
Time-resolved magnetic resonance angiography: Evaluation of intrapulmonary circulation parameters in pulmonary arterial hypertension.
- Published in:
- Journal of Magnetic Resonance Imaging, 2011, v. 33, n. 1, p. 225, doi. 10.1002/jmri.22428
- By:
- Publication type:
- Article
Don't judge a book by its cover: a case report of apolipoprotein A-IV cardiac amyloidosis.
- Published in:
- European Heart Journal Case Reports, 2023, v. 7, n. 8, p. 1, doi. 10.1093/ehjcr/ytad341
- By:
- Publication type:
- Article
Embarking upon atrial fibrillation management in heart failure with preserved ejection fraction: Charting a course.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. N.PAG, doi. 10.1371/journal.pone.0240567
- By:
- Publication type:
- Article
Relation of Sex Hormone Levels With Prevalent and 10-Year Change in Aortic Distensibility Assessed by MRI: The Multi-Ethnic Study of Atherosclerosis.
- Published in:
- American Journal of Hypertension, 2018, v. 31, n. 7, p. 774, doi. 10.1093/ajh/hpy024
- By:
- Publication type:
- Article
Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 7, p. 1469, doi. 10.1002/acr.24998
- By:
- Publication type:
- Article
Heart failure with preserved ejection fraction: treat now by treating comorbidities.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Heart Failure With Preserved Ejection Fraction.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
A candidate gene study reveals association between a variant of the Peroxisome Proliferator- Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 128, doi. 10.1186/s13075-015-0641-2
- By:
- Publication type:
- Article
Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 18, p. 3403, doi. 10.1093/cvr/cvac179
- By:
- Publication type:
- Article
Rasmussen-Torvik et al. Respond to "The Perfect Measure of Diastolic Dysfunction".
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Prevalence and Predictors of Diastolic Dysfunction According to Different Classification Criteria: The Coronary Artery Risk Development in Young in Adults Study.
- Published in:
- American Journal of Epidemiology, 2017, v. 185, n. 12, p. 1221, doi. 10.1093/aje/kww214
- By:
- Publication type:
- Article
Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose‐lowering therapy: A pre‐specified analysis of the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1539, doi. 10.1002/ejhf.3269
- By:
- Publication type:
- Article
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1334, doi. 10.1002/ejhf.3266
- By:
- Publication type:
- Article
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1324, doi. 10.1002/ejhf.3253
- By:
- Publication type:
- Article
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant‐level pooled analysis of DAPA‐HF and DELIVER.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 912, doi. 10.1002/ejhf.3184
- By:
- Publication type:
- Article
Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON‐HF study.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 871, doi. 10.1002/ejhf.3167
- By:
- Publication type:
- Article
Impact of COVID‐19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2177, doi. 10.1002/ejhf.3043
- By:
- Publication type:
- Article
Rationale and design of ENDEAVOR: A sequential phase 2b–3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1696, doi. 10.1002/ejhf.2977
- By:
- Publication type:
- Article
Influence of background medical therapy on efficacy and safety of dapagliflozin in patients with heart failure with improved ejection fraction in the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1663, doi. 10.1002/ejhf.3001
- By:
- Publication type:
- Article
Hypoxaemia in patients with heart failure and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1593, doi. 10.1002/ejhf.2930
- By:
- Publication type:
- Article
Effects of dapagliflozin on heart failure hospitalizations according to severity of inpatient course: Insights from DELIVER and DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1364, doi. 10.1002/ejhf.2912
- By:
- Publication type:
- Article
Renal and blood pressure effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction: Insights from the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 1170, doi. 10.1002/ejhf.2915
- By:
- Publication type:
- Article
Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant‐level pooled analysis from the DAPA‐HF and DELIVER trials.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 981, doi. 10.1002/ejhf.2909
- By:
- Publication type:
- Article
Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 6, p. 806, doi. 10.1002/ejhf.2805
- By:
- Publication type:
- Article
Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2307, doi. 10.1002/ejhf.2722
- By:
- Publication type:
- Article
Association of epicardial adipose tissue with proteomics, coronary flow reserve, cardiac structure and function, and quality of life in heart failure with preserved ejection fraction: insights from the PROMIS‐HFpEF study.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2251, doi. 10.1002/ejhf.2709
- By:
- Publication type:
- Article
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1892, doi. 10.1002/ejhf.2652
- By:
- Publication type:
- Article
Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE‐HF trial roll‐in cohort.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 8, p. 1410, doi. 10.1002/ejhf.2559
- By:
- Publication type:
- Article